Novanta Inc NOVT
We take great care to ensure that the data presented and summarized in this overview for NOVANTA INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NOVT
View all-
Black Rock Inc. New York, NY4.43MShares$715 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.86MShares$623 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.01MShares$324 Million0.04% of portfolio
-
Conestoga Capital Advisors, LLC1.3MShares$210 Million3.3% of portfolio
-
State Street Corp Boston, MA1.26MShares$203 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT959KShares$155 Million0.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL956KShares$154 Million0.45% of portfolio
-
Neuberger Berman Group LLC New York, NY907KShares$146 Million0.13% of portfolio
-
Geode Capital Management, LLC Boston, MA853KShares$138 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C3834KShares$135 Million0.17% of portfolio
Latest Institutional Activity in NOVT
Top Purchases
Top Sells
About NOVT
Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. It's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. In addition, its Precision Motion segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.
Insider Transactions at NOVT
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 17
2024
|
Thomas N Secor Director |
SELL
Open market or private sale
|
Direct |
928
-100.0%
|
$153,120
$165.0 P/Share
|
Jun 10
2024
|
Thomas N Secor Director |
SELL
Open market or private sale
|
Direct |
1,000
-51.87%
|
$158,000
$158.6 P/Share
|
Apr 01
2024
|
Matthijs Glastra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.82%
|
$865,000
$173.09 P/Share
|
Mar 01
2024
|
Brian S Young Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
6,119
-15.6%
|
$1,070,825
$175.0 P/Share
|
Feb 29
2024
|
Robert Buckley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-2.43%
|
$510,000
$170.4 P/Share
|
Feb 26
2024
|
Peter L Chang CAO-Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
488
-0.97%
|
$77,104
$158.25 P/Share
|
Feb 26
2024
|
Peter L Chang CAO-Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,527
+2.99%
|
-
|
Feb 26
2024
|
Brian S Young Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
965
-1.21%
|
$152,470
$158.25 P/Share
|
Feb 26
2024
|
Brian S Young Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,172
+2.66%
|
-
|
Feb 26
2024
|
Matthijs Glastra Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,598
-8.29%
|
$884,484
$158.25 P/Share
|
Feb 26
2024
|
Matthijs Glastra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,576
+15.0%
|
-
|
Feb 26
2024
|
Robert Buckley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,567
-1.02%
|
$405,586
$158.25 P/Share
|
Feb 26
2024
|
Robert Buckley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,307
+2.08%
|
-
|
Feb 20
2024
|
Robert Buckley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
935
+0.77%
|
-
|
Feb 20
2024
|
Robert Buckley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
415
-0.34%
|
$65,985
$159.87 P/Share
|
Feb 20
2024
|
Matthijs Glastra Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,175
-4.74%
|
$186,825
$159.87 P/Share
|
Feb 20
2024
|
Matthijs Glastra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,649
+9.66%
|
-
|
Feb 20
2024
|
Brian S Young Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
351
+0.91%
|
-
|
Feb 20
2024
|
Brian S Young Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
156
-0.41%
|
$24,804
$159.87 P/Share
|
Feb 07
2024
|
Robert Buckley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,500
-1.23%
|
$240,000
$160.23 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 29.5K shares |
---|---|
Grant, award, or other acquisition | 33.5K shares |
Bona fide gift | 41.5K shares |
Payment of exercise price or tax liability | 27K shares |
---|---|
Open market or private sale | 50K shares |
Bona fide gift | 41.5K shares |